R. Jalloul

Publications16
h-index5
Citations59
Highly Influential Citations2
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Shamseddine
  • 256 Publications • 4,263 Citations
  • A. Taher
  • 340 Publications • 7,281 Citations
  • M. Fukuoka
  • 519 Publications • 21,808 Citations
  • F. Fossella
  • 259 Publications • 16,097 Citations
  • Publications
  • Influence
A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.
UNLABELLED We assessed the efficacy and safety of a liposomal cisplatin (lipoplatin) and vinorelbine combination in metastatic breast cancer (MBC). Thirty-five patients were treated. The objective… Expand
  • 26
  • 1
[Metastases of leiomyosarcoma of the uterus localized in the small intestine].
  • 1
  • 1
Secondary adenocarcinoma of the urinary bladder from a primary gastric cancer.
Primary bladder tumor is a frequent urological malignancy, whereas the incidence of secondary bladder tumor from a distant organ is quite rare. Secondary bladder neoplasms represent no more than 3%… Expand
  • 10
  • PDF
Preliminary results of a phase II study of liposomal cisplatin-vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer (MBC).
1068 Background: The frequent use of anthracyclines and taxanes in breast cancer's adjuvant setting has lead to drug resistance and cardiac toxicity. This has raised the need for new agents in the… Expand
  • 6
A Clinical Phase II Study of Cisplatinum and Vinorelbine (PVn) in Advanced Breast Carcinoma (ABC)
Objectives:The effectiveness of cisplatinum and vinorelbine (PVn) as a salvage regimen in patients with metastatic breast cancer was reported in previous studies. This report is a pilot study… Expand
  • 5
A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer
Background: We tested a sequential combination regimen using cisplatin and vinorelbine (PVn) followed by docetaxel as first-line chemotherapy in a phase II clinical trial in metastatic breast cancer… Expand
  • 2
Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study.
AIMS The aim of this study is to evaluate the activity and toxicity of the combination docetaxel and irinotecan as first-line therapy for advanced non-small-cell lung cancer (NSCLC). MATERIALS &… Expand
  • 9
  • PDF
A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC)
822 Background: Based on our encouraging positive experience with Cisplatin and Vinorelbine combination (PVn) in first and second line for (MBC). Material and Methods: From August 2002 to August… Expand
P-573 Docetaxel-innotecan doublet chemotherapy as first-line therapy for advanced non-small cell lung cancer: A Phase II study
ARTICLE ORIGINAL/ORIGINAL ARTICLE DOCETAXEL AND IRINOTECAN AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER : A PILOT STUDY
...
1
2
...